Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000886466 | SCV001029973 | likely benign | Neurofibromatosis, type 2 | 2023-12-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001019252 | SCV001180584 | likely benign | Hereditary cancer-predisposing syndrome | 2019-02-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV001019252 | SCV002528207 | likely benign | Hereditary cancer-predisposing syndrome | 2022-03-04 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV000886466 | SCV004816424 | likely benign | Neurofibromatosis, type 2 | 2023-08-15 | criteria provided, single submitter | clinical testing |